Activated partial thromboplastin time prolonged


International normalised ratio increased


Blood thyroid stimulating hormone increased


Hodgkin's disease lymphocyte depletion type stage unspecified


Hodgkin's disease lymphocyte predominance type stage unspecified


Acute generalised exanthematous pustulosis


Drug reaction with eosinophilia and systemic symptoms


Electrocardiogram T wave amplitude decreased


Inappropriate antidiuretic hormone secretion


Postural orthostatic tachycardia syndrome


Hand and foot syndrome secondary to sickle cell anaemia


Posterior reversible encephalopathy syndrome


Refractory anaemia with an excess of blasts


Blood creatine phosphokinase MM increased


Acute promyelocytic leukaemia differentiation syndrome


Post transplant lymphoproliferative disorder


Blood follicle stimulating hormone increased


Activated partial thromboplastin time shortened


Red blood cell sedimentation rate increased


Mental disorder due to a general medical condition


Refractory cytopenia with unilineage dysplasia


Reversible ischaemic neurological deficit


Blood thyroid stimulating hormone decreased


Type III immune complex mediated reaction


Congenital central nervous system anomaly


Free prostate-specific antigen increased


International normalised ratio decreased


Blood creatine phosphokinase MB increased


Senile ankylosing vertebral hyperostosis


Pityriasis lichenoides et varioliformis acuta


Extranodal NK/T-cell lymphoma, nasal type


Detachment of retinal pigment epithelium


Epidermal growth factor receptor decreased


Antineutrophil cytoplasmic antibody positive


Tongue neoplasm malignant stage unspecified


Cardioactive drug level above therapeutic


Localised intraabdominal fluid collection


Increased viscosity of bronchial secretion